Search Results - "Madelaine, J"

The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer by Cho-Clark, Madelaine J, Watkins, Allison, Wu, T John

“…From the time of its discovery and isolation in the mammalian hypothalamus, the decapeptide, gonadotropin-releasing hormone (GnRH), has also been found to be…”
Get full text

Oil, gas, and rhesus monkeys: A new framework for natural resources under the commercial activity exception by Madelaine J Horn

“…Under the 'Foreign Sovereign Immunities Act of 1976' (FSIA), foreign states are presumptively immune from suits in US courts unless one of several enumerated…”
Get full text

Comparative transcriptome analysis between patient and endometrial cancer cell lines to determine common signaling pathways and markers linked to cancer progression by Cho-Clark, Madelaine J, Sukumar, Gauthaman, Vidal, Newton Medeiros, Raiciulescu, Sorana, Oyola, Mario G, Olsen, Cara, Mariño-Ramírez, Leonardo, Dalgard, Clifton L, Wu, T John

“…The rising incidence and mortality of endometrial cancer (EC) in the United States calls for an improved understanding of the disease's progression. Current…”
Get full text

Lung involvement of pyoderma gangrenosum: Diagnostic and therapeutic discussion based on a case report and a targeted literature review by Gallou, S, Madelaine, J, Planchard, G, Dumont, A, Audemard-Verger, A, Costa, C, Bergot, E, Aouba, A

“…Pyoderma gangrenosum (PG) is a rare, mainly dermatological condition, whose unusual and little-known lung involvement presents a diagnostic and therapeutic…”
Get full text

A randomized non-comparative phase II study of anti–PD-L1 ATEZOLIZUMAB or chemotherapy as second-line therapy in patients with small cell lung cancer: Results from the IFCT-1603 trial by Pujol, J.-L., Greillier, L., Audigier Valette, C., Moro-Sibilot, D., Uwer, L., Hureaux, J., Thiberville, L., Carmier, D., Madelaine, J., Otto, J., Gounant, V., Merle, P., Mourlanette, P., Molinier, O., Renault, P.A., Mazieres, J., Antoine, M., Langlais, A., Morin, F., Souquet, P.-J.

Get full text

Maintenance chemotherapy versus follow-up after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): IFCT-1201 MODEL randomised phase III trial by Quoix, E., Audigier Valette, C., Lavolé, A., Molinier, O., Westeel, V., Barlesi, F., Le Treut, J., Pichon, E., Dauba, J., Otto, J., Dumont, P., Moreau, L., Madelaine, J., Margery, J., Debieuvre, D., Renault, P.A., Langlais, A., Morin, F., Moro-Sibilot, D., Souquet, P.-J.

Get full text

Epidemiology, molecular biology, diagnostic and therapeutic strategy of malignant pleural mesothelioma in 2007 - an update by Porret, E, Madelaine, J, Galateau-Sallé, F, Bergot, E, Zalcman, G

“…Malignant pleural mesothelioma (MPM) is a rare tumour due to occupational asbestos exposure. The incidence of MPM will continue to increase until 2020-2030…”
Get more information

The place of targeted therapies in the management of non-small cell bronchial carcinoma. Biological mechanisms of bronchial carcinogenesis: towards a better understanding and the development of new therapies by Zalcman, G, Richard, N, Madelaine, J, Bergot, E

“…An increasing knowledge of cell signal transduction pathways has led to a better understanding of multi-step bronchial carcinogenesis. This new data has been…”
Get more information

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial by Peters, S., Dafni, U., Dómine, M., Popat, S., Andrade, J., Becker, A., Moro-Sibilot, D., Curioni-Fontecedro, A., Molinier, O., Nackaerts, K., Insa Mollá, A., López Vivanco, G., Madelaine, J., Faehling, M., Griesinger, F., González Larriba, J.L., Provencio Pulla, M., Vervita, K., Roschitzki-Voser, H., Ruepp, B., Mitchell, P., Le Pechoux, C., De Ruysscher, D., Stahel, R., Hiltbrunner, A., Gasca-Ruchti, A., Giacomelli, N., Kammler, R., Marti, N., Pfister, R., Piguet, A.C., Roux, S., Troesch, S., Schweri, R., Zigomo, I., Tsourti, Z., Tsouprou, S., Kassapian, M., Vervita, K., Dimopoulou, G., Andriakopoulou, C., Morin, F., Amour, E., Mariaule, G., Archirel, N., Fernandez, M., Pereira, E., Benito, L., Lopez, K., Hernández, A., Chinchen, S., Jurkovic, H., Livingstone, A., Walker, M., Mitchell, P., Ng, S., Steer, C., Briscoe, K., Saqib, A., O’Byrne, K., Chittajallu, B.R., Hughes, B.G., Black, A., Nackaerts, K., Werner, H., Gervais, R., Zalcman, G., Monnet, I., Moro-Sibilot, D., Molinier, O., Girard, N., Souquet, P.-J., Barlesi, F., Debieuvre, D., Senellart, H., Poudenx, M., Dixmier, A., Pouessel, D., Cadranel, J., Lena, H., Quoix, E., Friard, S., Audigier-Valette, C., Mazieres, J., Pichon, E., Faehling, M., Kokowski, K., Griesinger, F., Tufman, A., de Langen, J., González Larriba, J.L., Insa, A., Massutí, B., Pulla, M.P., Aix, S.P., Villanueva, N., Andrade, J., Curioni-Fontecedro, A., Franks, K., Califano, R.

“…Concurrent chemotherapy and thoracic radiotherapy followed by prophylactic cranial irradiation (PCI) is the standard treatment in limited-disease small-cell…”
Get full text

Abstract 944: The effects of GnRH-(1-5) on endometrial cancer cell lines by Larco, Darwin O., Cho-Clark, Madelaine J., Sorini, Maya, Lee, Cameron, Wu, T. John

“…The Gonadotropin-Releasing Hormone (GnRH) is a central regulator of reproductive function and behavior. In the periphery, GnRH is secreted by gynecologic…”
Get full text

LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC) by Girard, N., Mazieres, J., Otto, J., Lena, H., Lepage, C., Egenod, T., Smith, D., Madelaine, J., Gérinière, L., El Hajbi, F., Ferru, A., Clément-Duchêne, C., Madroszyk, A., Desrame, J., Morin, F., Langlais, A., Michel, P., Louvet, C., Westeel, V., Walter, T.

Get full text

1170O An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Characterisation of PORT efficacy in lung ART (IFCT-0503, UK NCRI, SAKK) by Le Pechoux, C., Barlesi, F., Pourel, N., Faivre-Finn, C., Lerouge, D., Zalcman, G., Antoni, D., Lamezec, B., Nestle, U., Boisselier, P., Thillays, F., Paumier, A., Dansin, E., Peignaux, K., Madelaine, J., Pichon, E., Larrouy, A., Riesterer, O., Lavolle, A., Bardet, A.

Get full text

Prise en charge diagnostique et thérapeutique du mésothéliome pleural malin en 2008 by Zalcman, G., Porret, E., Madelaine, J., Bergot, E.

“…Malignant pleural mesothelioma (MPM) is a rare tumour, secondary to professional asbestosis exposure. MPM incidence is rising since the late sixties and this…”
Get full text

LBA3_PR An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683 by Le Pechoux, C., Pourel, N., Barlesi, F., Faivre-Finn, C., Lerouge, D., Zalcman, G., Antoni, D., Lamezec, B., Nestle, U., Boisselier, P., Thillays, F., Paumier, A., Dansin, E., Peignaux, K., Madelaine, J., Pichon, E., Larrouy, A., Riesterer, O., Lavole, A., Bardet, A.

Get full text

LBA84 Consolidation ipilimumab and nivolumab vs observation in limited stage SCLC after chemo-radiotherapy: Results from the ETOP/IFCT 4-12 STIMULI trial by Peters, S., Pujol, J-L., Dafni, U., Dómine, M., Becker, A., Andrade, J., Curioni-Fontecedro, A., Molinier, O., Moro-Sibilot, D., Nackaerts, K., Mollá, A. Insa, López Vivanco, G., Madelaine, J., Popat, S., Reck, M., Roschitzki-Voser, H., Mitchell, P., De Ruysscher, D., Le Pechoux, C., Stahel, R.

Get full text

Foliage Type Controls Mercury Input, Storage, and Release in the Boreal Forest by Anderson, Madelaine J. R

“…Mercury (Hg) is a naturally occurring element with a complex biogeochemical cycle. Forests act as net sinks for both carbon (C) and Hg as foliage accumulates…”
Get full text

LBA56Maintenance chemotherapy versus follow-up after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): IFCT-1201 MODEL randomised phase III trial by Quoix, E, Audigier Valette, C, Lavolé, A, Molinier, O, Westeel, V, Barlesi, F, Le Treut, J, Pichon, E, Dauba, J, Otto, J, Dumont, P, Moreau, L, Madelaine, J, Margery, J, Debieuvre, D, Renault, P A, Langlais, A, Morin, F, Moro-Sibilot, D, Souquet, P-J

Get full text

1664OA randomized non-comparative phase II study of anti-PD-L1 ATEZOLIZUMAB or chemotherapy as second-line therapy in patients with small cell lung cancer: Results from the IFCT-1603 trial by Pujol, J-L, Greillier, L, Audigier Valette, C, Moro-Sibilot, D, Uwer, L, Hureaux, J, Thiberville, L, Carmier, D, Madelaine, J, Otto, J, Gounant, V, Merle, P, Mourlanette, P, Molinier, O, Renault, P A, Mazieres, J, Antoine, M, Langlais, A, Morin, F, Souquet, P-J

Get full text

Atteinte pulmonaire de pyoderma gangrenosum : discussion diagnostique et thérapeutique à partir d’un cas et d’une revue ciblée de la littérature by Gallou, S., Madelaine, J., Planchard, G., Dumont, A., Audemard-Verger, A., Costa, C., Bergot, E., Aouba, A.

“…Le pyoderma gangrenosum (PG) est une affection rare, essentiellement dermatologique, dont l’atteinte pulmonaire inhabituelle et peu connue, constitue un défi…”
Get full text

Ultrastructural basis of synaptic transmission between endbulbs of Held and bushy cells in the rat cochlear nucleus by Nicol, Madeleine J., Walmsley, Bruce

“…Auditory nerve fibres make large excitatory synaptic contacts, the endbulbs of Held, with bushy cells in the anteroventral cochlear nucleus (AVCN). We have…”
Get full text